Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548953 | PMC |
http://dx.doi.org/10.4097/kjae.2017.70.4.479 | DOI Listing |
Korean J Anesthesiol
August 2017
Department of Nephrology, Nagoya Kyoritsu Hospital, Aichi, Japan.
Anesth Analg
June 2007
Department of Anesthesiology, Henry Ford Hospital, Detroit, Michigan 48202-9888, USA.
Icodextrin, a peritoneal dialysate commonly used in the renal failure patient with diabetes, may lead to an overestimation of blood glucose levels as determined by bedside glucometers. This spurious hyperglycemia can lead to significant morbidity if unrecognized. We describe a case of severe hypoglycemia caused by an unappreciated overestimation of blood glucose in a diabetic patient with concomitant chronic renal failure requiring peritoneal dialysis with icodextrin.
View Article and Find Full Text PDFActa Clin Belg
March 2007
Department of Clinical Chemistry, University Hospital Gent, Belgium.
Recently a number of glucose dehydrogenase-based point of care (POCT) systems for glucose monitoring were successfully introduced on the market. Icodextrin, a glucose polymer is widely used as an osmotic agent in continuous ambulatory peritoneal dialysis (CAPD). Its metabolites are substrates for glucose dehydrogenase, inducing an analytical error which is gaining importance in the determination of glucose in a hospital environment.
View Article and Find Full Text PDFBMJ
September 2003
Institute of Nephrology, University Hospital of Wales, Heath Park, Cardiff CF14 4XN.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!